Supreme Court Report

Supreme Court of the United States · Official docket →

Boehringer Ingelheim Pharmaceuticals, Inc., et al. v. Beth Bacher, Representative for Paul Bacher, Deceased, et al.

Paid petition · United States Court of Appeals for the Second Circuit, No. 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885 · judgment July 23, 2024


Certiorari denied · January 27, 2025
Pre-decision estimate: 13% cert probability (95% interval 9%–18%)

Before the decision, about 3.1× the 4.1% base rate. The model weighted this up for a Second Circuit decision below, a circuit split argued in the petition, and a dissent in the court below (flagged in the petition).

Question presented

PATRICK M. FAHEY ANDREW T. BAYMAN SHIPMAN & GOODWIN LLP KING & SPALDING LLP One Constitution Plaza 1180 Peachtree St. NE Hartford, CT 06103 Atlanta, GA 30309

  1. 251-5000 (404) 572-4600 Counsel for Petitioners Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corp. JOSEPH G. PETROSINELLI AMY MASON SAHARIA JESSICA B. RYDSTROM WILLIAMS & CONNOLLY LLP 680 Maine Avenue, SW Washington, DC 20024

  2. 434-5000 Counsel for Petitioner Pfizer Inc.

Counsel of record

For petitioner
Daniel S. Pariser
Arnold and Porter Kaye Scholer LLP

For respondent
John Anthony Bruegger
Parafinczuk Wolf, P.A.

Case

Conference history
Distributed for 1 conference

Proceedings

  1. Jan 27 2025
    Petition DENIED.
  2. Jan 08 2025
    DISTRIBUTED for Conference of 1/24/2025.
  3. Jan 06 2025
    Reply of petitioners Boehringer Ingelheim Pharmaceuticals, Inc., et al. filed. (Distributed)
  4. Dec 20 2024
    Brief of respondents Beth Bacher, et al. in opposition filed.
  5. Oct 30 2024
    Motion to extend the time to file a response is granted and the time is extended to and including December 23, 2024. See Rule 30.1.
  6. Oct 28 2024
    Motion to extend the time to file a response from November 22, 2024 to December 22, 2024, submitted to The Clerk.
  7. Oct 21 2024
    Petition for a writ of certiorari filed. (Response due November 22, 2024)